Blau Farmacêutica S.A. (BLAU3.SA)

BRL 12.57

(-5.42%)

Operating Expenses Summary of Blau Farmacêutica S.A.

Blau Farmacêutica S.A.'s latest annual operating expenses in 2023 was 252.76 Million BRL , up 17.19% from previous year.
Blau Farmacêutica S.A.'s latest quarterly operating expenses in 2024 Q2 was 83.34 Million BRL , up 19.83% from previous quarter.
Blau Farmacêutica S.A. reported a annual operating expenses of 215.68 Million BRL in annual operating expenses 2022, up 4.1% from previous year.
Blau Farmacêutica S.A. reported a annual operating expenses of 207.18 Million BRL in annual operating expenses 2021, up 24.59% from previous year.
Blau Farmacêutica S.A. reported a quarterly operating expenses of 69.55 Million BRL for 2024 Q1, up 0.58% from previous quarter.
Blau Farmacêutica S.A. reported a quarterly operating expenses of 193.16 Million BRL for 2023 Q3, up 197.98% from previous quarter.

Annual Operating Expenses Chart of Blau Farmacêutica S.A. (2023 - 2015)

Historical Annual Operating Expenses of Blau Farmacêutica S.A. (2023 - 2015)

Year	Operating Expenses	Operating Expenses Growth
2023	252.76 Million BRL	17.19%
2022	215.68 Million BRL	4.1%
2021	207.18 Million BRL	24.59%
2020	166.28 Million BRL	29.13%
2019	128.77 Million BRL	-4.78%
2018	135.24 Million BRL	16.48%
2017	116.1 Million BRL	4.42%
2016	111.18 Million BRL	5.58%
2015	105.31 Million BRL	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	83.34 Million BRL	19.83%
2024 Q1	69.55 Million BRL	0.58%
2023 Q3	193.16 Million BRL	197.98%
2023 Q1	55.32 Million BRL	16.8%
2023 Q2	64.82 Million BRL	17.17%
2023 Q4	69.15 Million BRL	-64.2%
2023 FY	252.76 Million BRL	17.19%
2022 FY	215.68 Million BRL	4.1%
2022 Q4	47.36 Million BRL	-26.38%
2022 Q3	64.33 Million BRL	29.59%
2022 Q2	49.64 Million BRL	-6.93%
2022 Q1	53.34 Million BRL	-10.61%
2021 Q4	59.68 Million BRL	24.42%
2021 Q1	47.13 Million BRL	-12.4%
2021 Q3	47.96 Million BRL	-5.07%
2021 Q2	50.53 Million BRL	7.2%
2021 FY	207.18 Million BRL	24.59%
2020 Q2	37.28 Million BRL	12.08%
2020 FY	166.28 Million BRL	29.13%
2020 Q4	53.8 Million BRL	28.3%
2020 Q3	41.93 Million BRL	12.49%
2020 Q1	33.26 Million BRL	34.66%
2019 Q3	35.28 Million BRL	-4.05%
2019 Q2	36.77 Million BRL	10.17%
2019 Q1	33.37 Million BRL	-26.87%
2019 FY	128.77 Million BRL	-4.78%
2019 Q4	24.7 Million BRL	-29.99%
2018 Q2	29.5 Million BRL	1.31%
2018 FY	135.24 Million BRL	16.48%
2018 Q4	45.64 Million BRL	43.99%
2018 Q3	31.69 Million BRL	7.44%
2018 Q1	29.12 Million BRL	0.0%
2017 FY	116.1 Million BRL	4.42%
2016 FY	111.18 Million BRL	5.58%
2015 FY	105.31 Million BRL	0.0%

Peer Operating Expenses Comparison of Blau Farmacêutica S.A.

Name	Operating Expenses	Operating Expenses Difference
Hypera S.A.	2.71 Billion BRL	90.674%